119 related articles for article (PubMed ID: 10968278)
1. Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.
Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Stup TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem; 2000 Jan; 8(1):191-200. PubMed ID: 10968278
[TBL] [Abstract][Full Text] [Related]
2. Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements.
Keyes RF; Golebiewski WM; Cushman M
J Med Chem; 1996 Jan; 39(2):508-14. PubMed ID: 8558520
[TBL] [Abstract][Full Text] [Related]
3. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Cushman M; Insaf S; Paul G; Ruell JA; De Clercq E; Schols D; Pannecouque C; Witvrouw M; Schaeffer CA; Turpin JA; Williamson K; Rice WG
J Med Chem; 1999 May; 42(10):1767-77. PubMed ID: 10346929
[TBL] [Abstract][Full Text] [Related]
4. Cosalane and its analogues: a unique class of anti-HIV agents.
Zhan P; Li Z; Liu X
Mini Rev Med Chem; 2010 Sep; 10(10):966-76. PubMed ID: 20540707
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues.
Golebiewski WM; Keyes RF; Cushman M
Bioorg Med Chem; 1996 Oct; 4(10):1637-48. PubMed ID: 8931933
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments.
Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Fanwick PE; Cushman M
Bioorg Med Chem; 2001 Nov; 9(11):2827-41. PubMed ID: 11597463
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
Cushman M; Insaf S; Ruell JA; Schaeffer CA; Rice WG
Bioorg Med Chem Lett; 1998 Apr; 8(7):833-6. PubMed ID: 9871550
[TBL] [Abstract][Full Text] [Related]
8. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
9. Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
Santhosh KC; Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Mar; 44(5):703-14. PubMed ID: 11262081
[TBL] [Abstract][Full Text] [Related]
10. Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem Lett; 2000 Sep; 10(18):2149-52. PubMed ID: 10999491
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Cushman M; Golebiewski WM; McMahon JB; Buckheit RW; Clanton DJ; Weislow O; Haugwitz RD; Bader JP; Graham L; Rice WG
J Med Chem; 1994 Sep; 37(19):3040-50. PubMed ID: 7932526
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds.
Howard OM; Dong HF; Oppenheim JJ; Insaf S; Santhosh KC; Paul G; Cushman M
Bioorg Med Chem Lett; 2001 Jan; 11(1):59-62. PubMed ID: 11140734
[TBL] [Abstract][Full Text] [Related]
13. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight.
Cushman M; Wang PL; Chang SH; Wild C; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV activity of a series of cosalane amino acid conjugates.
Santhosh KC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem Lett; 2000 Nov; 10(22):2505-8. PubMed ID: 11086716
[TBL] [Abstract][Full Text] [Related]
15. 1,2,5-Benzothiadiazepine and pyrrolo[2,1-d]-[1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity.
Di Santo R; Costi R; Artico M; Massa S; Marongiu ME; Loi AG; De Montis A; La Colla P
Antivir Chem Chemother; 1998 Mar; 9(2):127-37. PubMed ID: 9875384
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
[TBL] [Abstract][Full Text] [Related]
17. Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region.
Velázquez S; Tuñón V; Jimeno ML; Chamorro C; De Clercq E; Balzarini J; Camarasa MJ
J Med Chem; 1999 Dec; 42(25):5188-96. PubMed ID: 10602704
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds.
Cushman M; Kanamathareddy S; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):337-42. PubMed ID: 1704066
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activity of cosalane.
Choo V
Lancet; 1993 Sep; 342(8873):733. PubMed ID: 8103830
[No Abstract] [Full Text] [Related]
20. Synthesis and anti-HIV evaluation of the novel 2-(m-chlorobenzyl)-4-substituted-7-methyl-1, 1, 3-trioxo-pyrazolo[4, 5-e] [1, 2, 4]thiadiazines.
Yan RZ; Liu XY; Xu WF; Pannecouque C; Witvrouw M; De Clercq E
Arch Pharm Res; 2006 Nov; 29(11):957-62. PubMed ID: 17146963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
